Clinical Trials › NCT06433765
Recruiting
A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
Sponsored by TG Therapeutics, Inc.
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 728
Target enrollment
1
U.S. states
Jun 2024
Start date
Mar 2035
Expected completion
Interventions / Treatments
No intervention
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
North Carolina1 site
Wilmington
MS centers in North Carolina
Compare treatment centers near a trial site by center type, providers and trials.
View North Carolina centersThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.